Printer Friendly

ATS MEDICAL ANNOUNCES FIRST CLINICAL IMPLANTS

 ATS MEDICAL ANNOUNCES FIRST CLINICAL IMPLANTS
 MINNEAPOLIS, May 11 /PRNewswire/ -- Manny Villafana, chairman and


chief executive officer of ATS Medical, Inc., a division of Helix BioCore, Inc. (NASDAQ-NMS: HLIX), announced today that the first human clinical implants of the ATS Medical(TM) valve were performed in six major European cardiovascular centers during the week of May 4, 1992. The implants, which were performed in centers in Switzerland, Germany, France and Belgium, were attended by the company's Medical Advisory Board consisting of Dr. Demetre M. Nicoloff, a world-renowned heart value surgeon and professor of surgery at the Minneapolis Heart Institute, and Dr. H. David Friedberg, a practicing cardiologist and professor of medicine and cardiology at the University of South Florida. The implants also were attended by Villafana.
 All six of the implants were successfully performed. The implanting surgeons at all centers were highly complimentary of the valve's design and ease of implantation. The company expects to continue with the clinical study of the valve throughout 1992, expanding the scope of the study as additional valve sizes become available. "We are beginning our clinical studies with our largest sized and most difficult valve and will monitor valve performance closely as we introduce additional sizes. We expect to have a full set of aortic and mitral valves available for international clinical implanters by the end of 1992. Clinical studies in the United States are expected to begin in 1993," said Villafana.
 ATS Medical, Inc. is a division of Helix Biocore, Inc. The company intends to change its name to ATS Medical, Inc. at its annual meeting of shareholders to be held on May 21, 1992. At that time, additional information concerning the clinical implants will be discussed. The company's common stock is traded on the NASDAQ/National Market System under the symbol HLIX, which will change to ATSI effective May 26, 1992.
 -0- 5/11/92
 /CONTACT: Manny Villafana of ATS Medical, 612-553-7736/
 (HLIX ATSI) CO: ATS Medical, Inc. ST: Minnesota IN: MTC SU: PDT


KH -- MN012 -- 8565 05/11/92 11:07 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:May 11, 1992
Words:341
Previous Article:PETRO PLUS INC. ANNOUNCES PROGRESS REPORT
Next Article:DRIVERS STILL NEEDED FOR 1992 MICHELIN-BUICK GRAND TOUR
Topics:


Related Articles
HELIX BIOCORE, INC., CHANGES NAME TO ATS MEDICAL, INC. AND UPDATES HUMAN IMPLANT STUDIES
VILLAFANA ANNOUNCES ATS MEDICAL, INC. YEAR END RESULTS
VILLAFANA ANNOUNCES ATS MEDICAL, INC. FIRST QUARTER RESULTS
VILLAFANA ANNOUNCES ATS MEDICAL, INC. SECOND QUARTER RESULTS
CLINICAL RESULTS REPORTED ON ATS MEDICAL VALVE
VILLAFANA ANNOUNCES ATS MEDICAL, INC. THIRD QUARTER RESULTS
ATS MEDICAL, INC. ANNOUNCES RECORD FOURTH QUARTER RESULTS AND CONTINUED CLINICAL SUCCESS WITH ITS HEART VALVE
ATS MEDICAL RECEIVES "CE MARK" APPROVAL
MANNY VILLAFANA PRAISES HCFA DECISION TO RECOMMENCE PAYMENT FOR TESTING OF EVOLUTIONARY MEDICAL DEVICES
ATS Medical to Participate in the American Association for Thoracic Surgery Meeting.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters